ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Accenture Named a Leader in Everest Group’s Veeva PEAK Services Matrix Assessment 2021

Accenture (NYSE: ACN) has been named a leader in Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210503005172/en/

Everest Group’s Veeva Services PEAK Matrix Assessment 2021 (Graphic: Business Wire)

Everest Group’s Veeva Services PEAK Matrix Assessment 2021 (Graphic: Business Wire)

Veeva helps life sciences enterprises manage customer databases, track drug development, and organize clinical trials. Everest Group assessed how 15 life sciences information technology (IT) providers’ use Veeva and named Accenture a leader for its market impact, vision, and capabilities.

“During the pandemic, the cloud has been invaluable to unlock data and improve collaboration across the ecosystem in the race to develop and get a vaccine to the world,” said Rob Saiter, managing director, Accenture Life Sciences. “The cloud is foundational to the digital transformation that will help speed treatment development and create more meaningful engagement with sites and patients to improve patient outcomes. Earning a leadership position in the Veeva PEAK Services Matrix Assessment is a testament to our teams’ expertise and successful partnering with our clients.”

The Everest Group Veeva PEAK Services Matrix® Assessment analyzed IT service providers' Veeva services capabilities, including market trends for Veeva service and enterprise sourcing considerations highlighting the strengths and limitations of each service provider. Everest noted that Accenture has a strong focus on talent and has also invested in building accelerators, solutions, and frameworks to expedite time-to-market for their clients.

“Accenture’s expertise in guiding strategy for cloud capabilities and demonstrated ability to carry out large-scale transformational engagement covering Veeva’s large portfolio of offerings have earned Accenture its leadership position,” said Chunky Satija, practice director at Everest Group. “This is essential given an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, and it’s quite clear the industry is increasingly switching to cloud-based technologies.”

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 537,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.